Histofi, Inc.

[Not Yet Scheduled]
Histofi, Inc. is enabling a new diagnostic accuracy, improving the reliability and decreasing the turnaround time for cancer diagnosis. We are currently collaborating with medical professionals utilizing digital pathology and precision medicine tools through our own software platform named, oncOS. It will help physicians in developing countries make informed decisions that will lead to the best outcome for patients. We aim to provide access to personalized cancer care in all regions.

oncOS is a combination of a digital and telepathology system rooted in quality image data gathering and processing. It brings first world cancer technology and medical experience to infrastructure and resource-scarce developing countries. Lack of access to quality diagnostic and therapeutic data by physicians in developing countries is a barrier to meaningful and personalized cancer care delivery. oncOS is taking a direct and simplified approach to a comprehensive cancer care delivery mechanism.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
oncOS platform with connected mobile app
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
photo
CEO
Histofi, Inc.